Reply 121053 Parmmoney, good question. I base my statement on the fact that too many small share transactions daily are offered below the Ask, then lower bids show up. Stepping lower by pennies. Someone is selling into those lower bids, and too often and too regular. I don't think I'm incorrect by saying if the sellers would not sell below the ask, to fill a bid, and then move lower - the share price would be $2-$4 range. Personally I really expect that much of a move once we see the current version of ENOS.
What many don't seem to understand, is that the project agreements tie up any communication about ENOS, as to how far advanced the device has come compared to the last demonstration. By expecting a PR for every patent to come down the pike, it just invites prying eyes by the competition. We know the functionality. It's not going to change into a race car! I'm of the same opinion as others that have previously stated that software is being tested for triple redundancy and safety. I'll give Mc the benefit of the doubt and say he tried to get more $$$ up front, but MDT probably said "if we give you all that you want, then the share price will go to the moon." And it's too soon for where we are in the process of integrating your IP. Or something to that effect. I'm OK with that, if some version of that happened so long as we get $40M for next license agreement, and 2x for each extension of milestones beyond #4. The good news is they can't keep these projects in the closet for much longer. To the end of the 4th milestone tops on ENOS, unless they extend the milestones. Then if that happens - shareholders will have to demand some type of disclosure PRIOR to the AGM, or Mc will risk getting voted off the island. Of course Mc could delay the AGM for some BS reason.
I'm surprised to read all of the chatter about endo, b/c Mc has barely been able to put one foot in front of the other, and now some of our associates think he's managing ENOS, endo, and HUGO all at the same time???? Again, I hear my Statistics Prof in my ear. Possible, but highly improbable. As far as endo goes, the current version of ENOS could possibly be a close design if the boom can be lowered far enough to get into position. Now, I'm not saying the snake arms, and insertion tube are the correct size or the extension (length of reach) of the insertion tube and arms extend far enough. I really think the endo development is still early. And I think something happens prior to mid-next year with news, or disclosure about ENOS or the MDT partnership. Regardless of the NDA's, leaks occur. Wall Street has ears. THEY are greedy. It only takes a few to get into buying shares and then many others will notice. Hopefully.
I also don't see how ColubrisMX fits b/c while they have a prototype, our insertion tube and snake arms are too large. Unless they have a patent that would be beneficial to us, I think our stable of IP surpasses theirs by a wide margin. Dan Kim has jumped twice and it wouldn't surprise me to see him posturing for a merger of IP, or a position at TMDI. Pure speculation on my part.
Good luck to all. Regards, BK.
